Wei Dang

Title: Wei Dang: Innovator in Antibody Development

Introduction

Wei Dang is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biotechnology. He holds three patents that focus on innovative antibody therapies aimed at treating various diseases. His work has the potential to impact the medical community significantly.

Latest Patents

Wei Dang's latest patents include the development of an anti-human MASP-2 antibody, which can specifically bind to human MASP-2. This antibody demonstrates good biological activity by inhibiting the cleavage of C4 and the generation of C3b, making it applicable in treating MASP-2 related diseases, such as IgA nephropathy. Another notable patent is the anti-PD-1 monoclonal antibody, which effectively binds to the extracellular region of the human PD-1 protein receptor. This antibody can block the binding of PD-1 with its ligand PD-L1, enhancing immunity and showing promise in tumor immunotherapy and the treatment of autoimmune diseases.

Career Highlights

Wei Dang has worked with notable companies in the biotechnology sector, including Shanghai Mabgeek Biotech Co., Ltd and Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His experience in these organizations has contributed to his expertise in antibody development and therapeutic applications.

Collaborations

Wei Dang has collaborated with esteemed colleagues, including Chenghai Zhang and Lingqiao Zhu, to advance his research and development efforts in the field of biotechnology.

Conclusion

Wei Dang's innovative work in antibody development positions him as a key figure in the biotechnology industry. His patents reflect a commitment to addressing critical health challenges through scientific innovation.